IXICO Plc (LSE:IXI) rose 6.67% on Monday, 5 October 2026, just days after the close of its financial year on 30 September. In July, the company raised its revenue guidance, saying it expected to beat market expectations, and investors are now positioning for a …
Fevara PLC (LSE:FVA) attracted attention on Monday, 5 October 2026, after its shares fell 5.54%. The move placed the livestock supplements specialist among the more notable decliners in London, at a time when domestically focused small and mid-cap stocks continued to struggle with a …
Verici Dx Plc (LSE:VRCI) rose 7.14% on Monday, 5 October 2026, as investors continued to digest the company's half-year results and its plans for additional funding. The kidney transplant diagnostics specialist has reported steady growth inDemandfor its Tutivia test, and the market appears to …
On 5 October 2026, AstraZeneca PLC announced the completion of its $2bn strategic investment in Summit Therapeutics. The investment, first announced in September 2026, is intended to accelerate the development of ivonescimab, which AstraZeneca describes as "a first-in-class bispecific antibody targeting PD-1 and VEGF", …
On 5 October 2026, AIM-quoted Avacta Group plc announced a proposed placing via an accelerated bookbuild and a subscription to raise approximately £12.5m before expenses. The fundraise is proposed, not completed: the bookbuild was expected to close at 7am on 6 October 2026, although …
Anpario is quoted on AIM and describes itself as "the independent manufacturer of natural sustainable animal feed additives for animal health, nutrition and biosecurity". Its products are sold to livestock producers and feed manufacturers around the world, through direct sales teams and distributors. Leading …
Oxford Biomedica is a contract development andManufacturingorganisation, or CDMO, specialising in viral vectors used in cell and gene therapies. Customers developing these treatments outsource process development and manufacturing to it. Headquartered in Oxford, the company has sites in Oxfordshire, Lyon and Strasbourg in France, …
Wellnex Life Limited, which is quoted on both the ASX and AIM under the ticker WNX, published a "Director's dealing" announcement on 5 October 2026. The company said it had been notified by Jeffrey Yeh, a non-executive director, of changes in his interest in …
With the share price trading at around a penny, even modest commercial updates can move the stock significantly. Investors appear to be positioning for contract conversions from its sales pipeline as the year draws to a close.
The company said it had agreed, at the request of investor Vulpes Investment Management, to extend the payment deadline for an outstanding £250,000 to 30 October 2026. Oxford BioDynamics, its nominated adviser SingerCapital Marketsand Merlin Partners, as parties to the placing agreement, agreed to …